List of insiders holdings for Inotiv Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Savanna Holdings LLC P2 Capital Partners LLC P2 Capital Master Fund I L.P. P2 Capital Fund IV L.P. MOLLER CLAUS J 10% Owner |
2022-09-20 09:01:30 | 8,125,178 127,516 |
8,252,694 | Form 4 |
2 | Leasure Robert Jr. President and CEO |
2025-03-18 17:39:56 | 1,816,052 105,000 |
1,921,052 | Form 4 |
3 | KISSINGER PETER KISSINGER CANDICE B 10% Owner |
2018-09-18 21:50:56 | 1,881,677 0 |
1,881,677 | Form 4 |
4 | BAKER ANDREW H Jermyn Street Associates LLC 10% Owner |
2024-04-03 10:47:10 | 1,260,024 0 |
1,260,024 | Form 13D |
5 | Costa Brava Partnership III LP Roark Rearden & Hamot LLC HAMOT SETH W 10% Owner |
2012-01-09 17:11:05 | 1,099,750 0 |
1,099,750 | Form 13D |
6 | Sagartz John E Chief Strategy Officer |
2025-03-18 16:07:39 | 737,816 0 |
737,816 | Form 4 |
7 | Sagartz Kimberly L 10% Owner |
2021-07-09 06:01:24 | 634,759 0 |
634,759 | Form 13G |
8 | SW Chrysalis LLC 10% Owner |
2019-04-24 20:34:02 | 632,475 0 |
632,475 | Form 13G |
9 | Cragg Scott Director |
2022-04-05 16:16:00 | 4,715 499,095 |
503,810 | Form 4 |
10 | Shepperd Richard M President & CEO |
2008-03-20 16:39:24 | 275,000 0 |
275,000 | Form 4 |
11 | Landman David Director |
2025-03-18 16:13:28 | 216,243 0 |
216,243 | Form 4 |
12 | Beattie John Gregory Chief Operating Officer |
2025-03-18 16:14:53 | 186,761 0 |
186,761 | Form 4 |
13 | Neff R Matthew Director |
2025-03-18 16:15:52 | 155,102 0 |
155,102 | Form 4 |
14 | Taylor Beth Chief Financial Officer |
2025-03-18 16:08:58 | 148,368 0 |
148,368 | Form 4 |
15 | Flynn Joseph Earl Chief Commercial Officer |
2021-05-11 16:32:36 | 128,394 0 |
128,394 | Form 4 |
16 | Brown Nigel Director |
2025-03-18 16:10:38 | 104,929 0 |
104,929 | Form 4 |
17 | EVANS DONNIE A Vice President Engineering |
2004-03-19 15:25:36 | 104,625 0 |
104,625 | Form 4 |
18 | Johnson Richard Allen Director |
2023-04-04 16:28:54 | 97,780 0 |
97,780 | Form 4 |
19 | SHOUP RONALD E Chief Scientific Officer |
2007-12-14 13:41:36 | 89,921 0 |
89,921 | Form 4 |
20 | Harrington Michael J Director |
2025-03-18 16:08:03 | 76,892 0 |
76,892 | Form 4 |
21 | Coelho Mary Theresa Director |
2025-04-02 16:32:56 | 74,303 0 |
74,303 | Form 4 |
22 | Pitchford William D Chief Human Resources Officer |
2022-12-29 07:12:01 | 74,051 0 |
74,051 | Form 4 |
23 | Lemke Jacqueline M President and CEO |
2016-03-02 17:04:03 | 60,685 9,000 |
69,685 | Form 4 |
24 | Davis Gregory Cole Director |
2023-04-04 16:28:38 | 67,780 0 |
67,780 | Form 4 |
25 | Hardy Adrian Chief Commercial Officer |
2025-03-18 16:15:20 | 58,420 0 |
58,420 | Form 4 |
26 | Oakley Daniel Thomas Chief Operating Officer |
2019-12-04 16:57:02 | 57,520 0 |
57,520 | Form 4 |
27 | Castetter Andrea SVP, Gen. Counsel & Secretary |
2025-03-18 16:14:07 | 55,000 0 |
55,000 | Form 4 |
28 | Krupp Jeffrey Arthur Chief Human Resources Officer |
2025-03-18 16:06:54 | 53,557 0 |
53,557 | Form 4 |
29 | Freeman Jeffrey Brennan VP-Finance & Corp. Controller |
2025-03-18 16:14:28 | 42,478 0 |
42,478 | Form 4 |
30 | Downing Philip A Sr. VP, Preclinical Srvcs. |
2022-02-23 17:22:46 | 42,195 0 |
42,195 | Form 4 |
31 | Harkness James Chief Operating Officer, RMS |
2022-03-16 10:47:25 | 38,968 0 |
38,968 | Form 4 |
32 | Hidalgo Alberto F Jr VP, Bus. Development & Mrkting |
2010-08-19 16:29:27 | 30,000 0 |
30,000 | Form 4 |
33 | BREWER JON VP Sales/Marketing |
2008-10-02 16:58:40 | 30,000 0 |
30,000 | Form 4 |
34 | CHAIT EDWARD Chief Business Officer |
2007-11-08 14:52:59 | 30,000 0 |
30,000 | Form 4 |
35 | Landis John B. Director |
2012-08-20 18:03:27 | 30,000 0 |
30,000 | Form 4 |
36 | SILVON MICHAEL P Vice President |
2004-03-02 15:59:07 | 30,000 0 |
30,000 | Form 4 |
37 | Garrett Michael Chief Commercial Officer |
2023-12-15 17:33:47 | 26,467 0 |
26,467 | Form 4 |
38 | Chilton Anthony S CEO and President |
2012-04-11 16:04:46 | 25,000 0 |
25,000 | Form 4 |
39 | HENNINGSEN GERRY Director BAS Evansville |
2004-03-02 15:48:51 | 20,000 0 |
20,000 | Form 4 |
40 | NOONE MICHAEL S Dir. of Clinical Affairs, Balt |
2004-03-02 15:47:18 | 20,000 0 |
20,000 | Form 4 |
41 | BRUNTLETT CRAIG S Senior V P, Sales Development |
2010-04-19 18:10:51 | 20,000 0 |
20,000 | Form 4 |
42 | REEVES-KERNER LINA L V.P. Human Resources |
2010-04-19 18:11:26 | 20,000 0 |
20,000 | Form 4 |
43 | COX MICHAEL R VP Finance & Administration |
2010-04-19 18:12:17 | 20,000 0 |
20,000 | Form 4 |
44 | Hodges Kathleen Vice President of Quality |
2010-04-19 18:17:10 | 20,000 0 |
20,000 | Form 4 |
45 | OMACHINSKI DAVID L Director |
2012-08-20 18:00:56 | 20,000 0 |
20,000 | Form 4 |
46 | DANIELS LESLIE B Director |
2010-08-18 16:31:22 | 15,000 0 |
15,000 | Form 4 |
47 | Boulet Larry Steven Director |
2012-08-20 18:02:02 | 15,000 0 |
15,000 | Form 4 |
48 | Baim Michael VP Bioanalytical Services |
2020-12-04 16:07:41 | 14,656 0 |
14,656 | Form 4 |
49 | BAITINGER WILLIAM E Director |
2008-09-08 16:18:46 | 12,000 0 |
12,000 | Form 4 |
50 | CRABB DAVID W Director |
2012-08-20 18:04:13 | 11,300 0 |
11,300 | Form 4 |
51 | Sullivan A. Charlene Director |
2012-08-20 18:06:31 | 10,000 0 |
10,000 | Form 4 |
52 | MCCLURE MARGARET B Dir, Pharmaceutical Lab. Div. |
2004-03-02 15:50:27 | 10,000 0 |
10,000 | Form 4 |
53 | Potrzebowski Jeffrey VP, Finance & CFO |
2014-06-10 16:40:53 | 10,000 0 |
10,000 | Form 4 |
54 | SAWYERS WILLIAM Laboratory Director Director |
2004-03-02 15:54:19 | 10,000 0 |
10,000 | Form 4 |
55 | Perrow Wendy Director |
2019-09-11 16:18:20 | 10,000 0 |
10,000 | Form 4 |
56 | Dougherty Connie Leigh VP, Business Development |
2016-05-27 16:05:51 | 9,074 0 |
9,074 | Form 4 |
57 | Blumhoff Jill VP, Finance & CFO |
2019-12-04 16:57:19 | 8,811 0 |
8,811 | Form 4 |
58 | Beraldi Fernanda Former Gen'l Counsel & Sec'y |
2024-01-10 17:19:15 | 7,840 0 |
7,840 | Form 4 |
59 | Devine John P VP--Toxicology |
2014-08-26 16:17:56 | 5,000 0 |
5,000 | Form 4 |
60 | Payne Lori VP-Bioanalytical Services |
2013-01-17 16:10:50 | 500 0 |
500 | Form 4 |
61 | Rohde-Johnson Candace A Director, Instruments Director |
2013-05-17 16:53:08 | 500 0 |
500 | Form 3 |
62 | Cordova Emilio V.P. of Business Development |
2007-11-28 11:43:20 | 34 100 |
134 | Form 4 |
63 | Bibi Mark L General Counsel and Secretary |
2022-03-01 16:33:04 | 0 0 |
0 | Form 4 |
64 | DOSTER GARYL W Director |
2004-08-20 17:22:30 | 0 0 |
0 | Form 3 |
65 | Bourdage James Sevall VP, Bioanalytical Services |
2014-06-19 16:16:13 | 0 0 |
0 | Form 3/A |
66 | Merrill R. Osheroff Director |
2014-01-30 16:01:19 | 0 0 |
0 | Form 3 |